Cargando…

Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material

BACKGROUND: Sensitive and reliable molecular diagnostics is needed to guide therapeutic decisions for cancer patients. Although less material becomes available for testing, genetic markers are rapidly expanding. Simultaneous detection of predictive markers, including mutations, gene amplifications a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steeghs, Elisabeth M. P., Kroeze, Leonie I., Tops, Bastiaan B. J., van Kempen, Leon C., ter Elst, Arja, Kastner-van Raaij, Annemiek W. M., Hendriks-Cornelissen, Sandra J. B., Hermsen, Mandy J. W., Jansen, Erik A. M., Nederlof, Petra M., Schuuring, Ed, Ligtenberg, Marjolijn J. L., Eijkelenboom, Astrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Technical Advance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137451/ https://www.ncbi.nlm.nih.gov/pubmed/32264863 http://dx.doi.org/10.1186/s12885-020-06785-6

Ejemplares similares

A multiplex PCR predictor for aCGH success of FFPE samples
por: van Beers, E H, et al.
Publicado: (2006)

Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
por: Eijkelenboom, Astrid, et al.
Publicado: (2019)

Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands
por: Wolff, Henri B., et al.
Publicado: (2022)

The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment
por: Dijkstra, Jeroen R., et al.
Publicado: (2015)

RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers
por: Boleij, Annemarie, et al.
Publicado: (2015)

Comprehensive molecular and clinicopathological analysis of vascular malformations: A study of 319 cases
por: Ten Broek, Roel W., et al.
Publicado: (2019)

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification
por: Meedendorp, Arenda D., et al.
Publicado: (2018)

“The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
por: Dinjens, Winand N. M., et al.
Publicado: (2020)

Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients
por: van der Leest, Paul, et al.
Publicado: (2020)

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
por: van der Leest, Paul, et al.
Publicado: (2021)

SimFFPE and FilterFFPE: improving structural variant calling in FFPE samples
por: Wei, Lanying, et al.
Publicado: (2021)

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
por: Koopman, Bart, et al.
Publicado: (2020)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

Functional characterisation of a novel class of in-frame insertion variants of KRAS and HRAS
por: Eijkelenboom, Astrid, et al.
Publicado: (2019)

Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
por: Keppens, Cleo, et al.
Publicado: (2019)

Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice
por: Steeghs, Elisabeth M. P., et al.
Publicado: (2021)

Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer
por: Saber, Ali, et al.
Publicado: (2016)

Profiling of the metabolic transcriptome via single molecule molecular inversion probes
por: de Bitter, Tessa, et al.
Publicado: (2017)

Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing
por: Allahyar, Amin, et al.
Publicado: (2021)

A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors
por: Boonstra, Pieter A., et al.
Publicado: (2018)

A High-Throughput Workflow for FFPE Tissue Proteomics
por: Pujari, Ganesh P., et al.
Publicado: (2023)

Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice
por: Steeghs, Elisabeth M P, et al.
Publicado: (2022)

Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
por: van den Heuvel, Guus R. M., et al.
Publicado: (2021)

Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients
por: Lassche, Gerben, et al.
Publicado: (2022)

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
por: Bisschop, Cornelis, et al.
Publicado: (2018)

The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor Blocks
por: van Wijk, Lise M., et al.
Publicado: (2021)

Multiplex bisulfite PCR resequencing of clinical FFPE DNA
por: Korbie, Darren, et al.
Publicado: (2015)

Use of FFPE-derived DNA in next generation sequencing: DNA extraction methods
por: McDonough, Samantha J., et al.
Publicado: (2019)

A critical spotlight on the paradigms of FFPE-DNA sequencing
por: Steiert, Tim A, et al.
Publicado: (2023)

Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival
por: Kryklyva, Valentyna, et al.
Publicado: (2020)

Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
por: Slootbeek, Peter H. J., et al.
Publicado: (2022)

Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
por: Slootbeek, Peter H. J., et al.
Publicado: (2021)

Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL
por: Deans, Zandra C, et al.
Publicado: (2016)

Effect of IKZF1 deletions on signal transduction pathways in Philadelphia chromosome negative pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
por: van der Sligte, Naomi E, et al.
Publicado: (2015)

Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular Characterization
por: de Bitter, Tessa J. J., et al.
Publicado: (2021)

Using ddPCR to assess the DNA yield of FFPE samples
por: Lu, X.J. David, et al.
Publicado: (2018)

Determinants of RNA Quality from FFPE Samples
por: von Ahlfen, Silke, et al.
Publicado: (2007)

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome
por: Reijnen, Casper, et al.
Publicado: (2020)

Modified SureSelect(QXT) Target Enrichment Protocol for Illumina Multiplexed Sequencing of FFPE Samples
por: Rosa-Rosa, J. M., et al.
Publicado: (2018)

Extraction-free whole transcriptome gene expression analysis of FFPE sections and histology-directed subareas of tissue
por: Trejo, Christy L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ttacojtcukbubikvith2jlgi4n